BioSpace.com

Biotech and Pharmaceutical
News & Jobs
Search the Site
 
   
Biotechnology and Pharmaceutical Channel Medical Device and Diagnostics Channel Clinical Research Channel BioSpace Collaborative    Job Seekers:  Register | Login          Employers:  Register | Login  

NEWSLETTERS
Free Newsletters
Archive
My Subscriptions

NEWS
News by Subject
News by Disease
News by Date
PLoS
Search News
Post Your News
JoVE

CAREER NETWORK
Job Seeker Login
Most Recent Jobs
Browse Biotech Jobs
Search Jobs
Post Resume
Career Fairs
Career Resources
For Employers

HOTBEDS
Regional News
US & Canada
  Biotech Bay
  Biotech Beach
  Genetown
  Pharm Country
  BioCapital
  BioMidwest
  Bio NC
  BioForest
  Southern Pharm
  BioCanada East
  US Device
Europe
Asia

DIVERSITY

INVESTOR
Market Summary
News
IPOs

PROFILES
Company Profiles

START UPS
Companies
Events

INTELLIGENCE
Research Store

INDUSTRY EVENTS
Biotech Events
Post an Event
RESOURCES
Real Estate
Business Opportunities

 News | News By Subject | News by Disease News By Date | Search News
eNewsletter Signup
Miles
Km80.5

   

Segasist launches Crowd-Funding Round for Cloud-Based Quality Assurance in Cancer Treatment


8/23/2012 11:08:12 AM

TORONTO, Aug. 21, 2012 /PRNewswire/ - Segasist Technologies, a Canadian software company developing next-generation image contouring platforms for biomedical applications, has launched a crowd funding campaign to bring its software Reconcillio on cloud.

Reconcillio is the first technology to provide quality assurance in treatment planning for radiation therapy. The software offers automated consensus contouring of tumor images, which increases the safety, accuracy and efficiency of radiation treatments. These markings, called contours, are crucial for efficient treatment. The more accurate the contours, the higher the success rate of killing cancer cells in a shorter time. Inaccurate contouring can lead to partial tumor radiation and damage to the surrounding healthy tissues.

Currently, there is no quality assurance for contouring. Cancer patients have to rely on the knowledge and contouring skills of their doctor. Unfortunately, it is well documented that clinicians, given the same image, generally produce different contours. Depending on the tumor type, size and location, studies have shown that clinicians' contours deviate considerably from each other ranging from 5% up to a frightening 60% difference. This long-standing problem is called "inter-observer variability" and results in suboptimal patient care and a more costly treatment.

"So, what is the solution?" asks Hamid Tizhoosh, the CEO of Segasist Technologies, "Ideally, we would have several doctors contour the tumor images of one patient. From this, a 'consensus contour' that reflects the collective knowledge of all the doctors is created to serve as a benchmark for accurate measurements. This approach can drastically reduce the variability and assure greater accuracy in treatment."

Reconcilio was designed because no healthcare system can afford such a multi-doctor approach.

"Taking this a step further" adds Tizhoosh, "our intention is to put this technology on the 'cloud' in order to extend the software to a large number of doctors and to cover many cancer cases. Software as a Service (SaaS) will enable any doctor to request 'consensus contours' at any time."

The crowd-funding project is accessible to potential supporters on "MedStartr.com": http://www.medstartr.com/projects/39-cloud-based-quality-assurance-for-cancer-treatment

Supporters receive different rewards, among others user/site licenses of Segasist contouring software that they can use themselves or donate to any hospital.

For more information contact: Dr. Hamid R. Tizhoosh, (647) 835-4077 or visit www.segasist.com


SOURCE Segasist Technologies



Read at BioSpace.com

 
 

ADD TO DEL.ICIO.US    ADD TO DIGG    ADD TO FURL    ADD TO STUMBLEUPON    ADD TO TECHNORATI FAVORITES